Delta4 Secures European Patents for Two Compounds as Candidate Treatments for Focal Segmental Glomerulosclerosis (FSGS)
AI and Computational Biology accelerate breakthrough therapy options: Delta4's Latest Milestone VIENNA, VIENNA, AUSTRIA, February 10, 2025 /EINPresswire.com/ -- Delta4, a leader in AI-driven drug discovery and indication expansion, is proud …